Skip to content

Clinical trials

Phase 2 Lymphoma, T-Cell trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, T-Cell Phase: Phase 2 Country / region: Italy Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20131
20182
20192
20201
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fondazione Italiana Linfomi - ETS2
Acrotech Biopharma Inc.1
BeiGene1
Innate Pharma1
Prescient Therapeutics, Ltd.1
SecuraBio1
miRagen Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, T-Cell8
Lymphoma, T-Cell, Cutaneous4
Lymphoma, T-Cell, Peripheral4
Lymphoma3
Mycosis Fungoides3
Recurrence3
Lymphoma, Non-Hodgkin2
Sezary Syndrome2
Immune System Diseases1
Immunoblastic Lymphadenopathy1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.